Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (801-810 of 1,052) with videos related to

Pageof 106
Sort By:
Cancer Research|March 17, 2007
Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancyHarjeet Singh, Lisa Marie Serrano, Timothy Pfeiffer, et al.
Cancer Immunology Research|March 21, 2019
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory PhenotypeDarya Alizadeh, Robyn A Wong, Xin Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2022
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor StudySaro H Armenian, Yanjun Chen, Lindsay Hageman, et al.
JAMA Oncology|June 3, 2016
Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor StudyMukta Arora, Can-Lan Sun, Kirsten K Ness, et al.
Transplantation and Cellular Therapy|June 13, 2024
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) TherapyScott R Goldsmith, Geoffrey Shouse, F Lennie Wong, et al.
The Journal of Infectious Diseases|October 21, 2006
Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipientsSimon F Lacey, Corinna La Rosa, Wendy Zhou, et al.
Blood Advances|December 21, 2021
Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS reportNora Balas, Lindsey Hageman, Jessica Wu, et al.
International Journal of Cancer|June 19, 2001
Clinical staging of prostate cancer: reproducibility and clarification of issuesT Campbell, J Blasko, E D Crawford, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse ratesRyotaro Nakamura, Nademanee Auayporn, David D Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
Pageof 106

Showing results (801-810 of 1,052) with videos related to

Sort By:
Pageof 106
Cancer Research|March 17, 2007
Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancyHarjeet Singh, Lisa Marie Serrano, Timothy Pfeiffer, et al.
Cancer Immunology Research|March 21, 2019
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory PhenotypeDarya Alizadeh, Robyn A Wong, Xin Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2022
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor StudySaro H Armenian, Yanjun Chen, Lindsay Hageman, et al.
JAMA Oncology|June 3, 2016
Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor StudyMukta Arora, Can-Lan Sun, Kirsten K Ness, et al.
Transplantation and Cellular Therapy|June 13, 2024
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) TherapyScott R Goldsmith, Geoffrey Shouse, F Lennie Wong, et al.
The Journal of Infectious Diseases|October 21, 2006
Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipientsSimon F Lacey, Corinna La Rosa, Wendy Zhou, et al.
Blood Advances|December 21, 2021
Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS reportNora Balas, Lindsey Hageman, Jessica Wu, et al.
International Journal of Cancer|June 19, 2001
Clinical staging of prostate cancer: reproducibility and clarification of issuesT Campbell, J Blasko, E D Crawford, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse ratesRyotaro Nakamura, Nademanee Auayporn, David D Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
Pageof 106